FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giulio Vistoli

Research Profile

Concepts & Ideas

Activities & Behaviors

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Eric Grouzmann; Jean-Baptiste Gualtierotti; Alessandro Pedretti; Bernard Testa; Karim Abid; Noureddine Brakch; Sandrine Gerber-Lemaire; Giulio Vistoli
Lack of enantioselectivity in the SULT1A3-catalyzed sulfoconjugation of normetanephrine enantiomers: an in vitro and computational study.
Han-Kun Zhang; Vadim Alexandrov; Daniela Brunner; J Brek Eaton; Allison Fedolak; Taleen Hanania; Ronald J. Lukas; Angelica Mazzolari; Mieke Nys; Emily Sabath; August B Smit; Chris Ulens; René Van Elk; Giulio Vistoli; Lifang Yu; Alan P Kozikowski
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.
Giulio Vistoli; Ermanno Valoti; Cristiano Bolchi; Laura Fumagalli; Marco Pallavicini; Alessandro Pedretti; Valentina Straniero; Bernard Testa
Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giulio Vistoli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eric Grouzmann; Jean-Baptiste Gualtierotti; Alessandro Pedretti; Bernard Testa; Karim Abid; Noureddine Brakch; Sandrine Gerber-Lemaire; Giulio Vistoli
Lack of enantioselectivity in the SULT1A3-catalyzed sulfoconjugation of normetanephrine enantiomers: an in vitro and computational study.
Chirality 2013;25(1):28-34.
2012: Han-Kun Zhang; Vadim Alexandrov; Daniela Brunner; J Brek Eaton; Allison Fedolak; Taleen Hanania; Ronald J. Lukas; Angelica Mazzolari; Mieke Nys; Emily Sabath; August B Smit; Chris Ulens; René Van Elk; Giulio Vistoli; Lifang Yu; Alan P Kozikowski
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.
Journal of medicinal chemistry 2012;55(18):8028-37.
2012: Giulio Vistoli; Ermanno Valoti; Cristiano Bolchi; Laura Fumagalli; Marco Pallavicini; Alessandro Pedretti; Valentina Straniero; Bernard Testa
Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis.
Chirality 2012;24(7):566-76.
2012: Giulio Vistoli; Marina Carini; Giancarlo Aldini
Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs.
Amino acids 2012;43(1):111-26.
2012: Bernard Testa; Alessandro Pedretti; Giulio Vistoli
Reactions and enzymes in the metabolism of drugs and other xenobiotics.
Drug discovery today 2012;17(11-12):549-60.
2012: Jay H Kalin; Giulio Vistoli; Hankun Zhang; Sophie Gaudrel-Grosay; Alan P Kozikowski
Chiral mercaptoacetamides display enantioselective inhibition of histone deacetylase 6 and exhibit neuroprotection in cortical neuron models of oxidative stress.
ChemMedChem 2012;7(3):425-39.
2011: Cristiano Bolchi; Laura Fumagalli; Cecilia Gotti; Francesco Pistillo; Luca Pucci; Ermanno Valoti; Giulio Vistoli; Matteo Binda; Marco Pallavicini
Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
Journal of medicinal chemistry 2011;54(21):7588-601.
2011: Alessandro Pedretti; Andrea Rosario Beccari; Alessandra Labozzetta; Matteo Lo Monte; Alessio Moriconi; Giulio Vistoli
Exploring the activation mechanism of TRPM8 channel by targeted MD simulations.
Biochemical and biophysical research communications 2011;414(1):14-9.
2011: Valeria Pittalà; Loredana Salerno; Maria Angela Siracusa; Giulio Vistoli; Alfredo Cagnotto; Tiziana Mennini; Maria Modica; Alessandro Pedretti; Giuseppe Romeo
Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
Bioorganic & medicinal chemistry 2011;19(17):5260-76.
2011: Alberto Milanese; Mehdi Rajabi; Elena Gorincioi; Giulio Vistoli; Enzo Santaniello
New synthesis of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid and evaluation of the influence of adamantyl group on the DNA binding of a naphthoic retinoid.
Bioorganic chemistry 2011;39(4):151-8.
2011: Alessandro Pedretti; Luca Regazzoni; Giancarlo Aldini; Laura De Luca; Cristina Marconi; Giulio Vistoli
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Bioorganic & medicinal chemistry 2011;19(15):4544-51.
2011: Marica Orioli; Alessandro Pedretti; Massimo Previtali; Luca Regazzoni; Giuseppe Rossoni; Giulio Vistoli; Renato Canevotti; Marina Carini; Luca Gamberoni; Annunziata Lapolla; Giancarlo Aldini
Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability.
ChemMedChem 2011;6(7):1269-82.
2011: Ilaria Bettinelli; Davide Graziani; Cristina Marconi; Alessandro Pedretti; Giulio Vistoli
The approach of conformational chimeras to model the role of proline-containing helices on GPCR mobility: the fertile case of Cys-LTR1.
ChemMedChem 2011;6(7):1217-27.
2011: Giulio Vistoli; Alessandro Pedretti; Bernard Testa
Chemodiversity and molecular plasticity: recognition processes as explored by property spaces.
Future medicinal chemistry 2011;3(8):995-1010.
2011: Giancarlo Aldini; Paola Braidotti; Gianpaolo Negrisoli; Marica Orioli; Giuseppe Rossoni; Federica Savi; Giulio Vistoli; Kyung-Jin Yeum; Marina Carini
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats.
Journal of cellular and molecular medicine 2011;15(6):1339-54.
2011: Luca Regazzoni; Raffaella Colombo; Laura Bertoletti; Giulio Vistoli; Giancarlo Aldini; Massimo Serra; Marina Carini; Roberto Maffei Facino; Sofia Giorgetti; Monica Stoppini; Gabriele Caccialanza; Ersilia De Lorenzi
Screening of fibrillogenesis inhibitors of β2-microglobulin: integrated strategies by mass spectrometry capillary electrophoresis and in silico simulations.
Analytica chimica acta 2011;685(2):153-61.
2010: Giulio Vistoli; Alessandro Pedretti; Angelica Mazzolari; Bernard Testa
Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.
Journal of computer-aided molecular design 2010;24(9):771-87.
2010: Kyle V Butler; Jay Kalin; Camille Brochier; Giulio Vistoli; Brett Langley; Alan P Kozikowski
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A.
Journal of the American Chemical Society 2010;132(31):10842-6.
2010: Luca Regazzoni; Laura Bertoletti; Giulio Vistoli; Raffaella Colombo; Giancarlo Aldini; Massimo Serra; Marina Carini; Gabriele Caccialanza; Ersilia De Lorenzi
A combined high-resolution mass spectrometric and in silico approach for the characterisation of small ligands of beta2-microglobulin.
ChemMedChem 2010;5(7):1015-25.
2010: Alessia Panusa; Giancarlo Aldini; Marica Orioli; Giulio Vistoli; Giuseppe Rossoni; Marina Carini
A sensitive and specific precursor ion scanning approach in liquid chromatography/electrospray ionization tandem mass spectrometry to detect methylprednisolone acetate and its metabolites in rat urine.
Rapid communications in mass spectrometry : RCM 2010;24(11):1583-94.
2010: Francesco Cilurzo; Chiara G M Gennari; Francesca Selmin; Giulio Vistoli
Effects of metal ions on entero-soluble poly(methacrylic acid-methyl methacrylate) coating: a combined analysis by ATR-FTIR spectroscopy and computational approaches.
Molecular pharmaceutics 2010;7(2):421-30.
2010: Giancarlo Aldini; Giulio Vistoli; Luca Regazzoni; Maria Carmela Benfatto; Ilaria Bettinelli; Marina Carini
Edaravone inhibits protein carbonylation by a direct carbonyl-scavenging mechanism: focus on reactivity, selectivity, and reaction mechanisms.
Antioxidants & redox signaling 2010;12(3):381-92.
2010: Giulio Vistoli; Alessandro Pedretti; Angelica Mazzolari; Bernard Testa
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations.
Bioorganic & medicinal chemistry 2010;18(1):320-9.
2009: Giulio Vistoli; Alessandro Pedretti; Angelica Mazzolari; Cristiano Bolchi; Bernard Testa
Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study.
Chemistry & biodiversity 2009;6(11):2092-100.
2009: Giulio Vistoli; Alessandro Pedretti; Bernard Testa
Partition coefficient and molecular flexibility: the concept of lipophilicity space.
Chemistry & biodiversity 2009;6(8):1152-69.
2009: Bernard Testa; Giulio Vistoli; Alessandro Pedretti; Andrzej Jacek Bojarski
Atomic diversity, molecular diversity, and chemical diversity: the concept of chemodiversity.
Chemistry & biodiversity 2009;6(8):1145-51.
2009: Giulio Vistoli; Marica Orioli; Alessandro Pedretti; Luca Regazzoni; Renato Canevotti; Gianpaolo Negrisoli; Marina Carini; Giancarlo Aldini
Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species.
ChemMedChem 2009;4(6):967-75.
2009: Giulio Vistoli; Alessandro Pedretti; Laura Alessandrini; Silvana Casati; Pierangela Ciuffreda; Giuseppe Meroni; Enzo Santaniello
Enhanced activity or resistance of adenosine derivatives towards adenosine deaminase-catalyzed deamination: Influence of ribose modifications.
Bioorganic & medicinal chemistry letters 2009;19(10):2877-9.
2009: Isabella Dalle-Donne; Marina Carini; Marica Orioli; Giulio Vistoli; Luca Regazzoni; Graziano Colombo; Ranieri Rossi; Aldo Milzani; Giancarlo Aldini
Protein carbonylation: 2,4-dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids.
Free radical biology & medicine 2009;46(10):1411-9.
2009: Giangiacomo Beretta; Giulio Vistoli; Enrico Caneva; Cecila Anselmi; Roberto Maffei Facino
Structure elucidation and NMR assignments of two new pyrrolidinyl quinoline alkaloids from chestnut honey.
Magnetic resonance in chemistry : MRC 2009;47(5):456-9.
2009: Alessandro Pedretti; Cristina Marconi; Ilaria Bettinelli; Giulio Vistoli
Comparative modeling of the quaternary structure for the human TRPM8 channel and analysis of its binding features.
Biochimica et biophysica acta 2009;1788(5):973-82.
2009: Marco Pallavicini; Cristiano Bolchi; Matteo Binda; antonio Cilia; Francesco Clementi; Rossana Ferrara; Laura Fumagalli; Cecilia Gotti; Milena Moretti; Alessandro Pedretti; Giulio Vistoli; Ermanno Valoti
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
Bioorganic & medicinal chemistry letters 2009;19(3):854-9.
2008: Alessandro Pedretti; Elisabetta Bocci; Roberto Maggi; Giulio Vistoli
Homology modelling of human DHCR24 (seladin-1) and analysis of its binding properties through molecular docking and dynamics simulations.
Steroids 2008;73(7):708-19.
2008: Alessandro Pedretti; Cristina Marconi; Cristiano Bolchi; Laura Fumagalli; Rossana Ferrara; Marco Pallavicini; Ermanno Valoti; Giulio Vistoli
Modelling of full-length human alpha4beta2 nicotinic receptor by fragmental approach and analysis of its binding modes.
Biochemical and biophysical research communications 2008;369(2):648-53.
2008: Giulio Vistoli; Alessandro Pedretti; Bernard Testa
Assessing drug-likeness--what are we missing?
Drug discovery today 2008;13(7-8):285-94.
2008: Giancarlo Aldini; Giulio Vistoli; Luca Regazzoni; Luca Gamberoni; Roberto Maffei Facino; Satoru Yamaguchi; Koji Uchida; Marina Carini
Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?
Chemical research in toxicology 2008;21(4):824-35.
2008: Giulio Vistoli; Alessandro Pedretti; Silvia Dei; Serena Scapecchi; Cristina Marconi; Maria Novella Romanelli
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Bioorganic & medicinal chemistry 2008;16(6):3049-58.
2008: Alessandro Pedretti; Laura De Luca; Cristina Sciarrillo; Giulio Vistoli
Fragmental modeling of human glutamate transporter EAAT1 and analysis of its binding modes by docking and pharmacophore mapping.
ChemMedChem 2008;3(1):79-90.
2008: L Michel Espinoza-Fonseca; Alessandro Pedretti; Giulio Vistoli
Structure and dynamics of the full-length M1 muscarinic acetylcholine receptor studied by molecular dynamics simulations.
Archives of biochemistry and biophysics 2008;469(1):142-50.
2007: Cristiano Bolchi; Marco Pallavicini; Chiara Rusconi; Luisa Diomede; Nicola Ferri; Alberto Corsini; Laura Fumagalli; Alessandro Pedretti; Giulio Vistoli; Ermanno Valoti
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency.
Bioorganic & medicinal chemistry letters 2007;17(22):6192-6.
2007: Giulio Vistoli; Alessandro Pedretti; Bernard Testa; Rosanna Matucci
The conformational and property space of acetylcholine bound to muscarinic receptors: an entropy component accounts for the subtype selectivity of acetylcholine.
Archives of biochemistry and biophysics 2007;464(1):112-21.
2007: Francesco Cilurzo; Francesca Selmin; Giulio Vistoli; Paola Minghetti; Luisa Montanari
Binary polymeric blends to microencapsulate nitroflurbiprofen: physicochemical and in silico studies.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;31(3-4):202-10.
2007: Alessandro Pedretti; Giulio Vistoli
Modeling of human ghrelin receptor (hGHS-R1a) in its close state and validation by molecular docking.
Bioorganic & medicinal chemistry 2007;15(8):3054-64.
2007: Giancarlo Aldini; Marina Carini; Giulio Vistoli; Takahiro Shibata; Yuri Kusano; Luca Gamberoni; Isabella Dalle-Donne; Aldo Milzani; Koji Uchida
Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement.
Biochemistry 2007;46(10):2707-18.
2007: Isabella Dalle-Donne; Marina Carini; Giulio Vistoli; Luca Gamberoni; Daniela Giustarini; Roberto Colombo; Roberto Maffei Facino; Ranieri Rossi; Aldo Milzani; Giancarlo Aldini
Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes.
Free radical biology & medicine 2007;42(5):583-98.
2006: Marco Pallavicini; Barbara Moroni; Cristiano Bolchi; antonio Cilia; Francesco Clementi; Laura Fumagalli; Cecilia Gotti; Fiorella Meneghetti; Loredana Riganti; Giulio Vistoli; Ermanno Valoti
Synthesis and alpha4beta2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes.
Bioorganic & medicinal chemistry letters 2006;16(21):5610-5.
2006: Marco Pallavicini; Laura Fumagalli; Marco Gobbi; Cristiano Bolchi; Simona Colleoni; Barbara Moroni; Alessandro Pedretti; C Rusconi; Giulio Vistoli; Ermanno Valoti
QSAR study for a novel series of ortho disubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
European journal of medicinal chemistry 2006;41(9):1025-40.
2006: Giulio Vistoli; Alessandro Pedretti; Marco Cattaneo; Giancarlo Aldini; Bernard Testa
Homology modeling of human serum carnosinase, a potential medicinal target, and MD simulations of its allosteric activation by citrate.
Journal of medicinal chemistry 2006;49(11):3269-77.
2006: Alessandro Pedretti; Marco Villa; Marco Pallavicini; Ermanno Valoti; Giulio Vistoli
Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis.
Journal of medicinal chemistry 2006;49(11):3077-85.
2006: Alessandro Pedretti; Giulio Vistoli; Cristina Marconi; Bernard Testa
Muscarinic receptors: A comparative analysis of structural features and binding modes through homology modelling and molecular docking.
Chemistry & biodiversity 2006;3(5):481-501.
2005: Laura De Luca; Giulio Vistoli; Alessandro Pedretti; Maria Letizia Barreca; Alba Chimirri
Molecular dynamics studies of the full-length integrase-DNA complex.
Biochemical and biophysical research communications 2005;336(4):1010-6.
2005: Giulio Vistoli; Alessandro Pedretti; Luigi Villa; Bernard Testa
Solvent constraints on the property space of acetylcholine. 2. Ordered media.
Journal of medicinal chemistry 2005;48(22):6926-35.
2005: Bernard Testa; Giulio Vistoli; Alessandro Pedretti
Musings on ADME predictions and structure-activity relations.
Chemistry & biodiversity 2005;2(11):1411-27.
2005: Giulio Vistoli; Alessandro Pedretti; Luigi Villa; Bernard Testa
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Journal of medicinal chemistry 2005;48(15):4947-52.
2005: Giancarlo Aldini; Isabella Dalle-Donne; Giulio Vistoli; Roberto Maffei Facino; Marina Carini
Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction.
Journal of mass spectrometry : JMS 2005;40(7):946-54.
2005: Laura Fumagalli; Cristiano Bolchi; Simona Colleoni; Marco Gobbi; Barbara Moroni; Marco Pallavicini; Alessandro Pedretti; Luigi Villa; Giulio Vistoli; Ermanno Valoti
QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
Bioorganic & medicinal chemistry 2005;13(7):2547-59.
2005: Giulio Vistoli; Alessandro Pedretti; Luigi Villa; Bernard Testa
Solvent constraints on the property space of acetylcholine. I. Isotropic solvents.
Journal of medicinal chemistry 2005;48(6):1759-67.
2004: Cristiano Bolchi; Paolo Catalano; Laura Fumagalli; Marco Gobbi; Marco Pallavicini; Alessandro Pedretti; Luigi Villa; Giulio Vistoli; Ermanno Valoti
Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
Bioorganic & medicinal chemistry 2004;12(18):4937-51.
2004: Alessandro Pedretti; Maria Elena Silva; Luigi Villa; Giulio Vistoli
Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.
Biochemical and biophysical research communications 2004;319(2):493-500.
2004: Alessandro Pedretti; Luigi Villa; Giulio Vistoli
VEGA--an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming.
Journal of computer-aided molecular design 2004;18(3):167-73.
2003: Laura De Luca; Alessandro Pedretti; Giulio Vistoli; Maria Letizia Barreca; Luigi Villa; Pietro Monforte; Alba Chimirri
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking.
Biochemical and biophysical research communications 2003;310(4):1083-8.
2002: Alessandro Pedretti; Luigi Villa; Giulio Vistoli
VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs.
Journal of molecular graphics & modelling 2002;21(1):47-9.
2002: Giulio Vistoli; Alessandro Pedretti; Luigi Villa; Bernard Testa
The solute-solvent system: solvent constraints on the conformational dynamics of acetylcholine.
Journal of the American Chemical Society 2002;124(25):7472-80.
2002: Alessandro Pedretti; Luigi Villa; Giulio Vistoli
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking.
Journal of medicinal chemistry 2002;45(7):1460-5.
1997: Alessandro Pedretti; Anna Maria Villa; Luigi Villa; Giulio Vistoli
Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock.
Farmaco (Società chimica italiana : 1989) 1997;52(6-7):487-91.